Look forward to seeing you all WMIS WMIC #molecular imaging #science #innovation UC Davis Research Jason Lewis Radiochem MSK UC Davis CMGI Julie Sutcliffe

Our goal

Glad to see that the NCCN agrees that either 18F-DCFPyL or 68Ga-PSMA-11 should be used for selection of patients for 177Lu-PSMA-617 radioligand therapy. Hopefully we can put this issue to rest as soon as possible! #PSMAPET - bit.ly/3LkJV2v

Also great to see 177Lu-PSMA-617 added to the NCCN guidelines. As expected post-chemo and post-ARTT. Nice speedy updates by the NCCN panel. #PSMARLT bit.ly/3LkJV2v

Impressive and inspiring talk by Jason Lewis Jason Lewis Radiochem MSK at the @CRUK_BI today. Jason gave us an excellent vision of the future for #PET imaging and #theranostics. Phenomenal data.

What are the three pillars of survival for a drug in development? Find out how the pioneering ImmunoPET technology works. ImaginAbInc speaks to Oxford Global at our In Vivo imaging discussion group. #OGcollab oxfordglobal.co.uk/resources/bett…

Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMA and Beyond @asco Education Book #ASCO22 ascopubs.org/doi/full/10.12… Andrei Gafita Louise Kostos Jeremie Calais ProsTIC

We invite all WMIC 2022 attendees to fill out our pre-conference survey! ✨We want your input and feedback on WIMIN events you'd like to see at the upcoming WMIC conference. Fill out a survey & have a chance to win a $25 Amazon gift cards✨ surveymonkey.ca/r/YCRVYJT WMIS WMIC

O. Sartor discusses the role of PSMA PET/CT for selecting patients for radioligand therapy. Thoughts? Please comment! ow.ly/aIhI50Jk05n #MedicalImaging #PETCT #ProstateCancer Oliver Sartor

Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer dlvr.it/SRC7Rq

How perfect. Dr Gambhir would be proud.

Thanks SNMMI for the 2022 Alavi-Mandell award for this JNM publication. Recognition goes to all authors. #PSMA #ProstateCancer #nuclearmedicine snmmi.org/AboutSNMMI/Con…

FAP session at Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting attracts packed audience sofie.com/2022/06/22/fap…

Current Issue: Fibrous Dysplasia Mimicking Skeletal Metastasis on 68Ga-FAPI PET Imaging dlvr.it/STN0Dh

Read the FDA's reasoning and remember that National Comprehensive Cancer Network (NCCN) and SNMMI guidelines support the use of other validated and FDA-approved imaging probes for PLUVICTO treatment stratification. ow.ly/i7uQ50JSg9o #PrecisionMedicine #NucMed #ProstateCancer

This is your last week to submit an abstract for WMIC! Submit by July 15th, 2022. Present your science in Miami and don't forget to book your hotel: wmis.org/wmic1/

Eisai Co. and partner Biogen Inc. said their Alzheimer’s drug lecanemab slowed the disease, becoming the first medicine to clearly blunt the progression of the most common type of dementia in a final-phase trial $BIIB

Very excited to test the ability of a novel molecular imaging agent targeting fibroblast activated protein (FAP) to pick up pancreatic cancer!” 𝓢𝓸𝓯𝓲𝓮 𝓡𝓸𝔂𝓮𝓻 @elcinzan NYU Langone Health ⁦Perlmutter Cancer Center at NYU Langone Health⁩ #imagingpancreaticcancer prnewswire.com/news-releases/…

In January, we launched our iPREDICT clinical trial globally in the US, Australia, and Europe. ​ We are proud to announce the first patient dosed in Australia.​ ​Read more here: imaginab.com/news-events/ne… #Australiabiotech #immunotherapy #immunooncology #clinicaltrials

linkedin.com/company/icpo-i…